Pentamethylquercetin (PMQ) reduces thrombus formation by inhibiting platelet function

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liang, Ming Lu ^a,b   Da, Xing Wen ^a,b   He, Ao Di ^a,b   Yao, Guang Qiang ^a,b   Xie, Wen ^a,b   Liu, Gang ^a,b   Xiang, Ji Zhou ^a,b,c   Ming, Zhang Yin ^a,b,c  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Key Laboratory for Drug Target Research and Pharmacodynamic Evaluation of Hubei Province   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 3,3',4',5,7-PENTAMETHYLQUERCETIN; ANTITHROMBOCYTIC AGENT; QUERCETIN; THROMBIN;

ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECTS; MOUSE; THROMBOCYTE; THROMBOSIS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; BLOOD PLATELETS; MICE; MICE, INBRED C57BL; PLATELET AGGREGATION INHIBITORS; QUERCETIN; THROMBIN; THROMBOSIS;

EID: 84931274952     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11142     Document Type: Article

References (38)

1. Michelson, A. D. Antiplatelet therapies for the treatment of cardiovascular disease. Nat. Rev. Drug Discov. 9, 154-169 (2010).
2. Li, Z., Delaney, M. K., O'Brien, K. A. & Du, X. Signaling during platelet adhesion and activation. Arterioscler Thromb. Vasc. Biol. 30, 2341-2349 (2010).
3. Perez-Vizcaino, F. & Duarte, J. Flavonols and cardiovascular disease. Mol. Aspects Med. 31, 478-494 (2010).
4. Janssen, K. et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. Am. J. Clin. Nutr. 67, 255-262 (1998).
5. Rechner, A. R. & Kroner, C. Anthocyanins and colonic metabolites of dietary polyphenols inhibit platelet function. Thromb. Res. 116, 327-334 (2005).
6. Hubbard, G. P. et al. Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: A pilot study. Br. J. Nutr. 96, 482-488 (2006).
7. Guerrero, J. A. et al. Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells. Br. J. Clin. Pharmacol. 64, 133-144 (2007).
8. Hubbard, G. P. et al. Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components of the glycoprotein VI signaling pathway. J. Thromb. Haemost. 1, 1079-1088 (2003).
9. Vilahur, G. & Badimon, L. Antiplatelet properties of natural products. Vascul. Pharmacol. 59, 67-75 (2013).
10. Wright, B., Spencer, J. P. E., Lovegroveb, J. A. & Gibbinsa, J. M. Flavonoid inhibitory pharmacodynamics on platelet function in physiological environments. Food Funct. 4, 1803-1810 (2013).
11. Wright, B., Gibson, T., Spencer, J., Lovegrove, J. A. & Gibbins, J. M. Platelet-Mediated Metabolism of the Common Dietary Flavonoid, Quercetin. PLoS ONE 5, e9673 (2010).
12. Wen, X. & Wall, T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab. Dispos. 34, 1786-1792 (2006).
13. Loke, W. M. et al. Metabolic transformation has a profound effect on anti-inflammatory activity of flavonoids such as quercetin: Lack of association between antioxidant and lipoxygenase inhibitory activity. Biochem. Pharmacol. 75, 1045-1053 (2008).
14. Wright, B. et al. A structural basis for the inhibition of collagen-stimulated platelet function by quercetin and structurally related flavonoids. British journal of pharmacology 159, 1312-1325 (2010).
15. Chen, X. et al. Simultaneous determination of 3,3',4',5,7-pentamethylquercetin and its possible metabolite 3,3',4',7-tetramethylquercetin in dog plasma by liquid chromatography-tandem mass spectrometry and its application to preclinical pharmacokinetic study. J. Chromatogr. B. 879, 2339-2344 (2011).
16. Hibasami, H. et al. Isolation of five types of flavonol from seabuckthorn (Hippophae rhamnoides) and induction of apoptosis by some of the flavonols in human promyelotic leukemia HL-60 cells. Int. J. Mol. Med. 15, 805-809 (2005).
17. Xiang, K. et al. 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro. Thromb. Res. 133, 211-217 (2014).
18. Gibbins, J. M. Platelet adhesion signalling and the regulation of thrombus formation. J. Cell Sci. 117, 3415-3425 (2004).
19. Suzuki-Inoue, K. et al. Association of Fyn and Lyn with the proline-rich domain of glycoprotein VI regulates intracellular signaling. J. Biol. Chem. 277, 21561-21566 (2002).
20. Watson, S. P. & Gibbins, J. Collagen receptor signalling in platelets: Extending the role of the ITAM. Immunol. Today 19, 260-264 (1998).
21. Jackson, S. P., Nesbitt, W. S. & Kulkarni, S. Signaling events underlying thrombus formation. J. Thromb. Haemost. 1, 1602-1612 (2003).
22. Abrams, C. S. Intracellular signaling in platelets. Curr. Opin. Hematol. 12, 401-405 (2005).
23. Ragab, A. et al. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: Insights into the mechanism of PLC gamma 2 activation. Blood 110, 2466-2474 (2007).
24. Weng, Z. et al. PTEN regulates collagen-induced platelet activation. Blood 116, 2579-2581 (2010).
25. Chen, J. et al. Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice. Blood 104, 1703-1710 (2004).
26. A.O'Brien, K., Stojanovic-Terpo, A., Hay, N. & Du, X. An important role for Akt3 in platelet activation and thrombosis. Blood 118, 4215-4223 (2011).
27. Li, D., August, S. & S.Woulfe, D. GSK3beta is a negative regulator of platelet function and thrombosis. Blood 111, 3522-3530 (2008).
28. Rivera, J., Lozano, M. L., Navarro-Núñez, L. & Vicente, V. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 94, 700-711 (2009).
29. Wright, B., Tindall, M. J., Lovegrove, J. A. & Gibbins, J. M. Investigating flavonoids as molecular templates for the design of small-molecule inhibitors of cell signaling. J. Food Sci. 78, N1921-1928 (2013).
30. McGrath, J., Drummond, G., McLachlan, E., Kilkenny, C. & Wainwright, C. Guidelines for reporting experiments involving animals: The ARRIVE guidelines. Br. J. Pharmacol. 160, 1573-1576 (2010).
31. Shen, J. Z. et al. Pentamethylquercetin generates beneficial effects in monosodium glutamate-induced obese mice and C2C12 myotubes by activating AMP-activated protein kinase. Diabetologia 55, 1836-1846 (2012).
32. Bank, S., Jana, P., Maiti, S., Guha, S. & Sinha, A. K. Dermcidin isoform-2 induced nullification of the effect of acetyl salicylic acid in platelet aggregation in acute myocardial infarction. Sci. Rep. 4, 5804 (2014).
33. Horjus, D. L. et al. Creatine kinase inhibits ADP-induced platelet aggregation. Sci. Rep. 4, 6551 (2014).
34. Ziu, E. et al. Effect of serotonin on platelet function in cocaine exposed blood. Sci. Rep. 4, 5945 (2014).
35. Zhou, Y.-J. et al. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates. Thromb Res. 132, 202-210 (2013).
36. Mosawy, S., Jackson, D. E., Woodman, O. L. & Linden, M. D. Treatment with quercetin and 3',4'-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo. J. Thromb. Thrombolysis 36, 50-57 (2013).
37. Day, S. M., Reeve, J. L., Myers, D. D. & Fay, W. P. Murine thrombosis models. Thromb. Haemost. 92, 486-494 (2004).
38. Wang, G. et al. Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42/p44 MAPK and NFkappaB pathways. Sci. Rep. 4, 4905 (2014).